December 28, 2012 Aeterna Zentaris Granted Special Protocol Assessment by the FDA for Phase 3 Registration Trial in Endometrial Cancer with AEZS-108

[at noodls] – December 28, 2012 Aeterna Zentaris Granted Special Protocol Assessment by the FDA for Phase 3 Registration Trial in Endometrial Cancer with AEZS-108 Québec City, Canada, December 28, 2012 – Aeterna Zentaris … more

View todays social media effects on AEZS

View the latest stocks trending across Twitter. Click to view dashboard

See who AEterna is hiring next, click here to view